Three doses of 15mg/kg IV TXA reduces blood loss vs. placebo in trochanteric fracture surgery
Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trialHong Kong Med J. 2019 Apr;25(2):120-126.
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
176 patients with trochanteric fractures and scheduled for surgical treatment were randomized to receive 3 doses of intravenous tranexamic acid or placebo (normal saline). Outcomes of interest included peri-operative, obivous and hidden blood loss, post-operative hemoglobin levels, proportion of patients who received red blood cell transfusion, number of transfused red blood cell units per person,...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE